Gen H reduces mortgage rates by up to 0.20%
The lender has reduced two and five-year rates across its range, including New Build Boost.
Gen H has reduced two and five-year fixed mortgage rates by up to 0.20%.
Five-year rates between 60% and 80% LTV are down by 0.20% and two-year rates by 0.15%.
New Build Boost rates are also dropping by 0.10% to 6.29% for an effective rate of 5.30%.
With New Build Boost, buyers bring a 5% deposit, take an 80% mortgage with Gen H, and receive a 15% interest-free equity loan to close the gap. As buyers only pay interest on the 80% mortgage, this makes the total cost similar to 95% LTV products at 5.30%.
The latest cuts come as Gen H announces improvements in underwriting efficiency. The number of first-touch underwrites done by the lender has doubled, and 35% of cases receive an offer within three days.
Sara Palmer, sales and distribution director at Gen H, said: “As we’ve shown throughout the year, we move as quickly as we can to cut rates when swap movements allow. And this is not the only good news this week - we’re delighted that our underwriting improvements are able to bring speed and certainty to even more of your clients with more first-touch offers than ever before.”
Breaking news
Direct to your inbox:
More
stories
you'll love:
This week's biggest stories:
Iress
Iress expands mortgage and protection distribution through new Access FS platform
FCA
Advice firm employees plead guilty after defrauding clients of £2m
Atom Bank
Try Mortgage Network adds Atom Bank to residential mortgage panel
FCA
MPs call for investigation into FCA's treatment of whistleblowers
This week's biggest stories:
Iress
Iress expands mortgage and protection distribution through new Access FS platform
FCA
Advice firm employees plead guilty after defrauding clients of £2m
Atom Bank
Try Mortgage Network adds Atom Bank to residential mortgage panel
FCA
MPs call for investigation into FCA's treatment of whistleblowers
Mortgage Rates
Average five-year fixed rate mortgage hits 6%
Inflation
Inflation could return to target by end of 2027, economist predicts